Eka Ventures Fund II

About Eka Ventures Fund II

Eka Ventures Fund II is an £80M ($107M) fund at hard cap, oversubscribed. Invests pre-seed and seed in UK startups across preventative health, sustainable consumption, and access to essential services. Fund I ranks top 5% globally on Cambridge Associates for both TVPI and DPI. Total AUM ~$200M.

Investment Focus

Location / RegionUnited Kingdom

Funding StagePre Seed

Industry Focus

Climate Sustainability

Digital Health

Wellness Lifestyle

Investor Signals Profile

active

Sweet Spot

UK pre-seed/seed consumer tech founder solving preventative health, sustainability, or essential services

preventative health

sustainable consumption

essential services

consumer tech

impact investing

Bullish Signals

Fund I top 5% globally on TVPI and DPI per Cambridge Associates benchmarkblog

77% LP re-up rate signals deep institutional conviction in Eka's strategyblog

Hard cap hit with oversubscription; seven Fund II deals already deployedblog

AI sourcing platform drove 47% of Fund I deals, structural edge at pre-seedblog

Contrarian Signals

Leads 90% of deals; will not follow consensus or compete on crowded termsblog

Concentrated 30-company portfolio — rejects index-style diversificationblog

Impact must be core business driver, not mission statement veneerblog

Founder Do's

Build in preventative health, sustainable consumption, or essential services (housing, insurance, education)

Demonstrate impact as core to the business model, not a marketing wrapper

Be open to Eka leading or co-leading your round

Target pre-seed or seed stage with a clear path to Series A

Be reachable proactively — Eka's AI sourcing finds companies before they raise

Founder Don'ts

Don't treat impact as superficial ESG branding — Eka will scrutinise authenticity

Don't expect a large portfolio slot — only 30 companies per fund, selectivity is high

Don't pitch if you are outside the UK or post-seed stage

Key GPs & Partners

Jon Coker

Co-Founder / General Partner

thesis-drivenmetrics-drivenex-founder

Camilla Dolan

Co-Founder / General Partner

thesis-drivenhands-onpatient-capital

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size£80M

Saves0

Website

Key People

Jon Coker, Camilla Dolan

Jon CokerCo-Founder / General Partner

Camilla DolanCo-Founder / General Partner